What is the appropriate acute and preventive management for a 33-year-old man with a three‑year history of migraine who presents with a 20‑day severe right‑sided pulsatile headache, photophobia, nausea/vomiting, normal examination and laboratory studies, and inability to undergo MRI?

Acute and Preventive Management Recommendation

For this patient with severe, prolonged migraine unresponsive to current therapy, immediately escalate acute treatment to combination therapy with a triptan plus naproxen (not naproxen alone), and initiate proper preventive therapy with topiramate (not sodium valproate as currently prescribed) or propranolol as first-line options 1, 2.

Critical Problems with Current Management

The current treatment approach has several significant deficiencies:

Acute Treatment Failures

• Naproxen monotherapy is inadequate for this patient's moderate-to-severe migraine. The 2025 ACP guideline explicitly states that for moderate-to-severe attacks, combination therapy (triptan + NSAID) should be used, not NSAID monotherapy 1.
• The patient was advised naproxen 500 mg once daily but didn't follow through—this suggests either inadequate counseling about early treatment or the regimen wasn't aggressive enough for symptom control.
• Sodium valproate 250 mg twice daily is being used incorrectly as acute therapy—valproate is a preventive medication, not an acute treatment 2.

Preventive Treatment Issues

• Topiramate 12.5 mg is a subtherapeutic dose for migraine prevention. Effective preventive doses typically range from 50-200 mg daily 2, 3.
• The patient has a 3-year history with current severe 20-day headache—this clearly indicates need for robust preventive therapy, which has been inadequately addressed.

Immediate Acute Management Algorithm

Step 1: Prescribe Combination Therapy

• Sumatriptan 50-100 mg (or alternative triptan) + Naproxen 500 mg at migraine onset 1
• Add metoclopramide 10 mg given the recurrent vomiting 1, 4
• Counsel to treat early after onset—waiting reduces efficacy 1, 5

Step 2: Route Selection

• Given severe nausea/vomiting, consider non-oral triptan formulation (nasal spray or subcutaneous sumatriptan 6 mg) 1, 6
• Subcutaneous sumatriptan is most effective for severe attacks with vomiting 4

Step 3: Rescue Plan

• If no response in 2 hours, may repeat triptan dose (maximum 2 doses/24 hours for most triptans)
• Avoid opioids and butalbital—these are explicitly not recommended 1, 6

Preventive Therapy Initiation

This patient clearly needs preventive therapy given:

• 3-year migraine history
• Current 20-day severe headache episode
• Functional disability (photophobia, vomiting, inability to work)

First-Line Preventive Options (Choose One)

Option A: Topiramate 2, 3

• Start 25 mg at bedtime
• Increase by 25 mg weekly
• Target dose: 50-100 mg daily (can go to 200 mg if needed)
• Advantages: Effective for migraine prevention, may help with weight if patient is overweight
• Monitor: Cognitive side effects, kidney stones, metabolic acidosis

Option B: Propranolol 2, 3

• Start 40 mg twice daily
• Target dose: 80-240 mg daily in divided doses
• Advantages: Well-established efficacy, may help if patient has hypertension or anxiety
• Contraindications: Asthma, heart block, severe bradycardia
• This patient's HR is 78 bpm—propranolol is safe

Option C: Metoprolol 2, 4

• Start 25-50 mg twice daily
• Target dose: 100-200 mg daily
• Similar profile to propranolol but more cardioselective

Why NOT Sodium Valproate for This Patient

• While valproate is effective 2, 4, it has significant concerns:
  • Teratogenicity (critical in 33-year-old male who may have female partners of childbearing age)
  • Weight gain
  • Hepatotoxicity
  • Tremor, hair loss
• Topiramate or beta-blockers are preferred first-line agents 2, 3

Medication Overuse Headache Risk

Critical caveat: This 20-day continuous headache raises concern for medication overuse headache (MOH), though the history doesn't clearly document overuse patterns 1.

• MOH threshold: ≥10 days/month for triptans, ≥15 days/month for NSAIDs 1
• If patient has been using acute medications frequently, this may be contributing to the prolonged headache
• Management: Initiate preventive therapy while carefully monitoring acute medication use
• Counsel patient to limit triptan use to <10 days per month 1

The MRI Issue Requires Resolution

The inability to complete MRI due to possible metal object is concerning:

Red flags that mandate imaging:

• While this patient's exam is reassuring (normal fundoscopy, normal neurologic exam), the 20-day continuous severe headache is atypical for typical migraine
• The X-ray showing "tiny radiopacity" needs clarification
• Strongly recommend:
  • Detailed history about any prior procedures, dental work, shrapnel, or foreign body exposure
  • Consider CT head with contrast as alternative if MRI truly contraindicated
  • This is a 33-year-old with new-onset severe prolonged headache—secondary causes must be excluded

Treatment Timeline and Monitoring

Week 1-2:

• Initiate combination acute therapy (triptan + naproxen + antiemetic)
• Start preventive medication at low dose
• Resolve imaging issue (CT if MRI impossible)

Week 2-8:

• Titrate preventive medication to therapeutic dose over 4-6 weeks 2, 3
• Monitor headache frequency, severity, disability using headache diary
• Assess for adverse effects

Month 2-3:

• Adequate trial duration is 2-3 months at therapeutic dose 2, 5, 3
• If <50% reduction in headache frequency, consider switching to alternative first-line preventive
• If medication overuse suspected, address this directly

Lifestyle Modifications (Non-Negotiable Adjuncts)

While initiating pharmacotherapy, counsel on 1:

• Hydration: Maintain consistent fluid intake
• Sleep hygiene: Regular sleep schedule (critical for migraine control)
• Regular meals: Avoid prolonged fasting
• Aerobic exercise: 30-40 minutes, 3-4 times weekly
• Stress management: Consider mindfulness or relaxation techniques
• Trigger identification: Keep headache diary to identify patterns

Common Pitfalls to Avoid

1. Using NSAIDs alone for moderate-severe migraine—this patient needs combination therapy 1
2. Inadequate preventive dosing—12.5 mg topiramate is essentially placebo 2
3. Insufficient trial duration—must give preventive therapy 2-3 months at therapeutic dose 2, 3
4. Treating preventive medications as acute therapy—valproate doesn't abort acute attacks 2
5. Ignoring medication overuse—this may be perpetuating the current 20-day headache 1
6. Failing to obtain imaging—20-day continuous severe headache warrants exclusion of secondary causes

Alternative Considerations if First-Line Fails

If patient doesn't respond to or tolerate initial preventive therapy after adequate trial 2, 3:

Second-line preventives:

• Amitriptyline 25-150 mg at bedtime
• Venlafaxine 150 mg daily
• Candesartan 16 mg daily

Newer agents (if available and affordable):

• CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) 2, 3
• Oral gepants for prevention (atogepant) 2

For acute treatment failures:

• Consider gepants (rimegepant, ubrogepant) if triptans contraindicated or ineffective 1, 6
• Ditans (lasmiditan) as last resort for acute treatment 1, 6